Oncolytics Biotech

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ONCY and other ETFs, options, and stocks.

About ONCY

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

CEO

Matthew C. Coffey

CEOMatthew C. Coffey

Employees

—

Employees—

Headquarters

Calgary, Alberta

HeadquartersCalgary, Alberta

Founded

1998

Founded1998

Employees

—

Employees—

ONCY Key Statistics

Market cap

80.34M

Market cap80.34M

Price-Earnings ratio

-3.45

Price-Earnings ratio-3.45

Dividend yield

—

Dividend yield—

Average volume

368.90K

Average volume368.90K

High today

$1.08

High today$1.08

Low today

$1.01

Low today$1.01

Open price

$1.06

Open price$1.06

Volume

260.23K

Volume260.23K

52 Week high

$3.39

52 Week high$3.39

52 Week low

$0.883

52 Week low$0.883

ONCY News

TipRanks 4d

Oncolytics Biotech Sets Virtual Annual Meeting - TipRanks.com - TipRanks

Oncolytics Biotech (TSE:ONC) has released an update. Oncolytics Biotech Inc. announces its upcoming annual general meeting to be held virtually on May 15, 2024...

TipRanks 5d

Oncolytics Biotech Targets FDA Approval for Cancer Drug - TipRanks.com - TipRanks

Oncolytics Biotech (TSE:ONC) has released an update. Oncolytics Biotech Inc. has announced the submission of a Type C meeting request to the FDA to discuss a r...

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell